Despite improved methods of diagnosis and the development of different treatments,
mortality from lung cancer remains surprisingly high. Non-small cell lung cancer (NSCLC) …

Simple Summary There are few established treatment options for recurrent glioblastoma
(rGBM). Immunotherapy, which potentiates the immune system to counter tumor growth …

Simple Summary Due to the increase of molecular biomarkers to be characterized to tailor
therapeutic strategies for non-squamous non-small cell lung carcinoma (NS-NSCLC), it is …

We are witnessing a silent revolution in the treatment of early stage non-small cell lung
cancer (NSCLC), with a series of practice-changing clinical trials enriching the therapeutic …

While surgical resection is the gold standard treatment for solid tumors, cancer recurrence
after surgery is common. Immunosurveillance of remnant tumor cells is an important …

Background Some locally advanced (IIIA/IIIB) non-small cell lung cancers (NSCLCs) might
have surgical options available. However, information regarding the effectiveness of …

Non-small cell lung cancer (NSCLC) cells exhibit aberrant metabolism characterized by high
glycolysis even in the presence of abundant oxygen. Inhibition of aerobic glycolysis remains …

Deregulation of apoptosis signaling is an important feature of cancer cells and plays an
essential role in tumorigenesis. Xanthohumol is an active ingredient in Traditional Chinese …

Background The impact of neoadjuvant chemoimmunotherapy on pulmonary resection and
related outcomes had been poorly reported in previous studies. The present study aims to …

Brain tumors are one of the leading causes of cancer related death in both the adult and
pediatric patient population. Gliomas represent a cohort of brain tumors derived from glial …